Repurposing Ribavirin for Oncology: Integrating Metabolism, Signaling, and Translational Control

Journal of Pharmacology and Experimental Therapeutics · Published 2026-08-01 · DOI 10.1016/j.jpet.2026.105001

Authors (4)

Amrita Talukder Mohini, Chibuike Emmanuel Okafor, Joseph M. Schober, Bhargav A. Patel

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mohini, A., Okafor, C., Schober, J., et al. (2026). Repurposing Ribavirin for Oncology: Integrating Metabolism, Signaling, and Translational Control. Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/j.jpet.2026.105001

Related articles

• IMPDH inhibition enhances cytarabine efficacy in SAMHD1 ‐expressing leukaemia cells via guanine nucleotide depletion · Molecular Oncology · 2026 · Cites or is cited by this article
• The Impact of ARL13B Regulation on IMPDH-Based Cytoophidia Formation and PC-3 Cells’ Proliferation and Migration · Molekulyarnaya Biologiya · 2025 · Cites or is cited by this article
• DSP-2342, a novel 5-hydroxytryptamine 2A/7 receptor antagonist, has therapeutic potential for behavioral and psychological symptoms of dementia · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Structure-based prediction of muscarinic M1/M3 receptor antagonist activity: Curated dataset and scaffold-aware evaluation · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Improving drug delivery to mitigate cisplatin nephrotoxicity · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Striatal remodeling in Parkinson disease · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Preclinical pharmacology of N-pyrrolidino “nitazene” opioids appearing in nonmedical drug markets · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Modulation of morphine tolerance and dependence by pyrroloquinoline quinone in mice: Insights into mechanistic bridge from N-methyl-D-aspartate receptors-calcium/calmodulin-dependent protein kinase II signaling to oxidative neuroinflammation · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Comparative analysis of ligand binding affinities and functional profiles at recombinant human β-adrenergic receptor subtypes 1, 2, and 3 · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• An antidote in arms: A monoclonal antibody intervention to reverse fentanyl-induced respiratory apnea · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal